Hydroxychloroquine
هیدروکسیکلروکین
🪱 Antiparasitic Products, Insecticides And RepellentsAntimalarial / DMARD
Market / country: 🇺🇸 USA
Plaquenil (US)
🧮 Dose calculator
Rheumatoid arthritis · Regimen source: FDA Hydroxychloroquine · 2.3
- • Maintenance 200–400 mg/day. More than 5 mg/kg/day (actual weight) increases retinopathy. FDA Hydroxychloroquine · 2.3
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to 4-aminoquinolines. FDA Hydroxychloroquine · 4
- ⛔ Children under 31 kg (200 mg tablet cannot be divided). FDA Hydroxychloroquine · 2.2
Monitoring
- • Baseline and periodic retinal examination (retinopathy). FDA Hydroxychloroquine · 5
Formulations
- 200 mg tablet — tablet 🇺🇸 USA FDA Hydroxychloroquine · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Hydroxychloroquine · 8.1
“Risk Summary Prolonged clinical experience over decades of use and available data from published epidemiologic and clinical studies with hydroxychloroquine sulfate tablets use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal, or fetal outcomes ( see …”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Hydroxychloroquine · 8.2
“Risk Summary Published lactation data report that hydroxychloroquine is present in human milk at low levels.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Hydroxychloroquine · 8.4
“The safety and effectiveness of hydroxychloroquine sulfate tablets have been established in pediatric patients for the treatment of uncomplicated malaria due to P. falciparum, P. malariae, P. vivax , and P. ovale, as well as for the prophylaxis of malaria in geographic areas where chloroquine resistance is not …”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Hydroxychloroquine · 8.5
“In general, dose selection in geriatric patients should start with the lowest recommended dose, taking into consideration the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA040081
- DailyMed (FDA label)FDA Hydroxychloroquine
- MedlinePlus (NIH)Hydroxychloroquine
- WHO ATC/DDDP01BA02
- Darooyab (Iran)Hydroxychloroquine
🇮🇷 Registered in Iran Darooyab · G-841/Hydroxychloroquine
Dosage forms with Iranian generic codes, per Darooyab.
- 01825 · HYDROXYCHLOROQUINE 200MG TAB · قرص هیدروکسیکلروکین ۲۰۰ میلیگرم
- 14059 · HYDROXYCHLOROQUINE 60MG TAB · قرص هیدروکسیکلروکین ۶۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Hydroxychloroquine · 3FDA Hydroxychloroquine · 2.3FDA Hydroxychloroquine · 2.2FDA Hydroxychloroquine · 4FDA Hydroxychloroquine · 5FDA Hydroxychloroquine · 8.1FDA Hydroxychloroquine · 8.2FDA Hydroxychloroquine · 8.4FDA Hydroxychloroquine · 8.5FDA Hydroxychloroquine · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-841/Hydroxychloroquine
- Clinical review⚠ Unverified